At-home care for breast cancer patients using an e-health app
Official title: At-home Breast Oncology Care Delivered With E-health Solutions The ABODE Study
Run by University Health Network, Toronto · NCT05989477 · Data updated 2026-11-12
This study is testing whether using a special app for breast cancer patients, along with their regular care, can help them feel more involved in their treatment compared to just receiving standard care alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | University Health Network, Toronto Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Toronto, Ontario) |
| Status | Recruiting |
| Started | June 22, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2028 |
| Registry record updated | October 30, 2026 |
| Trial ID | NCT05989477 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are females aged 18 and older, diagnosed with primary invasive breast cancer who will undergo surgery as their first treatment step.
✕Probably not a fit
Patients with non-operable or metastatic breast cancer, or those with significant hearing or visual challenges, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates a multi-dimensional remote eHealth solution designed for newly diagnosed breast cancer patients. Participants will be randomly assigned to either use a Breast Cancer Treatment Application (app) alongside standard care or receive standard care alone. The app facilitates virtual consultations, provides educational materials, and collects patient-reported outcome measures (PROMs). The primary objective is to assess changes in patient activation over one year, while secondary outcomes will include additional PROMs and data from wearable devices.
Why it matters
Potential benefit: If successful, this approach could enhance patient engagement and self-management in breast cancer care.
How similar studies have gone: Other studies have shown promise in using e-health solutions for patient engagement, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Females (assigned female at birth)\* * Diagnosed with first, primary invasive BC * Must have surgery as their first step in treatment pathway * Age≥18 * Access to an electronic device with connection to the internet * A valid email address * Can communicate in English \*Since BC risk is sex-related and based on physiological values, our inclusion criteria are based on sex (not gender) Exclusion criteria: * Males (assigned male at birth), as BC surgical treatment options and experiences are different * Diagnosed with non-operable breast cancer * Stage 4/metastatic (whether determined at diagnosis or during surgery) * Those with hearing or visual challenges * Neo-adjuvant chemotherapy * Should not be enrolled in any other UHN study using an e-Health application * Breast cancer surgery is scheduled for less 5 business days after enrollment
Where it's running
-
Tulin Cil
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Tulin Cil, MD, MEd — University Health Network, Toronto
- Study coordinator: Tulin Cil, MD, MEd
- Email: tulin.cil@uhn.ca
- Phone: 416-946-4507
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
QoR-15T in Cardiac Surgery: Turkish QoR-15T Validation in Elective Cardiac Procedures
A prospective group of adults having elective heart surgery will test whether the Turkish QoR-15T questionnaire accurately measures their recovery.
-
Improving PTSD treatment through patient engagement strategies
This study is testing if adding extra support like motivation sessions and shared decision-making can help people with PTSD stick with their treatment and feel better compared to standard care.
-
Egyptian MTA and Biodentine versus Calcium Hydroxide for indirect pulp capping in permanent teeth
This will test whether Egyptian MTA or Biodentine work better than calcium hydroxide for indirect pulp capping in adults with deep cavities to help keep the tooth's pulp healthy.
-
Digital education for osteoporosis patients to see if it lowers fracture risk
A digital education program for people over 65 with osteoporosis is being tested to see if it lowers fractures and improves medication use and quality of life compared with standard care.
-
Database for robotic-assisted prostate cancer surgeries
This study is gathering information from hospitals to see how well robotic surgeries for prostate cancer work and how they compare to traditional surgeries for patients in Australia.
-
Using a smartphone app to help lung cancer patients stick to their rehabilitation exercises after surgery
This study is testing whether a smartphone app can help lung cancer patients stick to their rehabilitation exercises after surgery by allowing them to report their symptoms and get feedback from their doctors.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.